|HOUSE MEETS AT:||FIRST VOTE PREDICTED:||LAST VOTE PREDICTED:|
|10:00 a.m.: Morning Hour
11:00 a.m.: Legislative Business
Fifteen “One Minutes”
|1:45 – 2:30 p.m.||6:00 – 7:00 p.m.|
|**Members are advised that the House is expected to recess following one minute speeches.
H.R. 5247 – Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (Rep. Fitzpatrick – Energy and Commerce) (One hour of debate). This is the same bill that failed on the Floor last Monday as a suspension bill. That vote can be found here.
H.R. 5247 threatens to undermine the drug development process and subject patients to serious risk of harm. Proponents of the bill argue that it will enable seriously ill patients to access unapproved, experimental drugs that could be potentially life-saving. However, the FDA already has an “expanded access” program in place to enable terminally ill patients to access investigational drugs. Under the expanded access program, 99.7% of all expanded access requests for patients with immediately life-threatening illnesses are approved by the FDA. Often when patients are denied access to these treatments it is due to the lack of availability of the drug or a pharmaceutical company’s concern about dangerous side effects. This bill will do nothing to compel manufacturers to provide drugs to these patients.
This bill would also weaken FDA’s ability to oversee adverse events or other clinical outcomes from the use of an investigational drug and provide broad liability protections for manufacturers and health care providers —leaving patients with no recourse in the case of an adverse event. This unnecessary legislation ultimately seeks to undermine the FDA’s authority to ensure safety and efficacy in the nation’s drug supply while providing false hope to patients.
The Rule, which was adopted yesterday, provides for one hour of general debate equally divided and controlled by the Committee on Energy and Commerce.
H.R. 4061 – Financial Stability Oversight Council Improvement Act (Rep. Ross – Financial Services) (One hour of debate). This measure would change the procedures that federal regulators follow for determining which nonbank financial institutions should be designated by the Financial Stability Oversight Council (FSOC) as systemically important financial institutions (SIFIs) and subject to heightened supervision due to their systemic risk. For example, the bill would increase the frequency and complexity of studies, reviews, and meetings that must be completed before the FSOC can designate a nonbank company as a SIFI. The bill also would allow companies to contest existing SIFI designations on the basis of the new criteria and procedures in addition to the current appeals process provided under Dodd-Frank. The Obama Administration opposed the bill last Congress.
The Rule, which was adopted last week, provides for one hour of general debate equally divided and controlled by the Committee on Financial Services.
Bill Text for H.R. 4061:
Postponed Suspensions (4 bills)
The GOP Leadership has announced the following schedule for Thursday, March 22: The House will meet at 9:00 a.m. for legislative business. The House may consider legislation making further appropriations for FY18.
Members are advised that additional legislative items are possible.
|THE DAILY QUOTE|
|“‘This is frustrating for a lot of us,’ said Sen. Mike Rounds (R., S.D.), noting that lawmakers have known for weeks that the funding deadline was approaching. ‘The fact that we are struggling to get it done, the deadline’s coming up—is not the way we should be doing business here.’”
- Wall Street Journal, 3/21/2018